BMFM, ***********OT************
If you want some diversification in your portfolio, look at Vivus (VVUS). They manufacture Muse, the alternative treatment to Viagra (male impotence pill). It is severely beaten-up due to Viagra, made by Phizer (PFE) taking huge market share. However, it just received an upgrade from a hold to a strong buy from one of roughly 5 analysts that cover it, due to an anticipated associated sales rise (no pun) from all of the attention on male impotence and to "treat" men that are unable to get an erection from Viagra (which is only 50 - 70% effective). The stock shot from $8 to $14 on the initial story and has since settled back down to $10. The stock has traded as high as $40's.
Muse, while it involves delivering (using a patented delivery system)a small pill directly, into you know where, is far more effective in the hard to treat cases. It also can be introduced 10 minutes before an erection is wanted whereas Viagra has to be taken one hour before. The company is profitable, and the consensus for '99 is around $1.40, putting the PE @ 7.5. Not bad value for a "bio-tech". I bought @ 10 5/8 on Thur.
Is that diverse enough for you Bald Man? <g> And I am in know way suggesting that you have need for the product<ggg>.
If nothing else a good distraction from all the money I (we) saw vanish on Friday!
Larry |
